THE SCRIPPS RESEARCH INSTITUTE
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1924-12-11
- Employees
- 1K
- Market Cap
- -
- Website
- https://powermom.scripps.edu
Clinical Trials
28
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (27 trials with phase data)• Click on a phase to view related trials
A Study to Assess CLBR001+SWI019 in Subjects With Autoimmune Diseases
- Conditions
- Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)
- First Posted Date
- 2025-04-06
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 12
- Registration Number
- NCT06913608
Long Term Follow-up Study for Subjects Administered CLBR001
- Conditions
- Long Term Follow-Up
- First Posted Date
- 2025-03-18
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 40
- Registration Number
- NCT06882317
A Study to Assess CLBR001+ABBV-461 in Subjects With Locally Advanced or Metastatic Breast Cancer
- Conditions
- Breast Cancer MetastaticLocally Advanced Breast Cancer (LABC)Malignant Neoplasm of BreastTriple Negative Breast Cancer (TNBC)Hormone Receptor-Positive Breast CancerHER2 + Breast Cancer
- Interventions
- Biological: Two Component Product CLBR001 + ABBV-461
- First Posted Date
- 2025-03-14
- Last Posted Date
- 2025-07-15
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 20
- Registration Number
- NCT06878248
- Locations
- 🇺🇸
Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis, Indiana, United States
🇺🇸Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸University of Virginia, Charlottesville, Virginia, United States
Study to Assess CMR316 in Healthy Volunteers and Patients With Idiopathic Pulmonary Fibrosis
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 106
- Registration Number
- NCT06589219
- Locations
- 🇩🇪
Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover, Germany
Study to Assess PDM608 in Healthy Adult Subjects
- First Posted Date
- 2023-07-18
- Last Posted Date
- 2024-08-06
- Lead Sponsor
- Calibr, a division of Scripps Research
- Target Recruit Count
- 64
- Registration Number
- NCT05950906
- Locations
- 🇺🇸
Quotient Sciences-Miami, Inc, Miami, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 6
- Next
News
Rosemary-Derived Compound Shows Promise as Potential Alzheimer's Treatment in Preclinical Study
Researchers at The Scripps Research Institute have developed diAcCA, a stable derivative of carnosic acid found in rosemary and sage, which enhanced memory and brain density in mouse models of Alzheimer's disease.